Cyclometalated Iridium Research Articles

Synthetic ease and exceptional in vivo performance of pyrazole-based cyclometallated iridium complexes

Novel cyclometallated IrIII complexes, exhibiting dual functionality as potent anticancer agents and photosensitisers, with selective efficacy against specific cancer cell lines.

Impacts of ancillary ligand coordination modes on red-emitting cyclometalated iridium complexes

Red-phosphorescent bis-cyclometalated iridium compounds with salicylaldimine, 2-picolinamide, and related ancillary ligand classes are described; the 2-picolinamide analogues exhibit multiple binding modes that influence photophysical properties.

Efficient reductive amination of 5-hydroxymethylfurfural by iridium-catalysed transfer hydrogenation

Transfer hydrogenative reductive amination of 5-(hydroxymethy)furfural (HMF) has been accomplished, catalysed by a cyclometalated iridium catalyst with formic acid as a hydrogen source.

Aqueous emissive cyclometalated iridium photoreductants: synthesis, computational analysis and the photocatalytic reduction of 4-nitrophenol.

Herein, we present luminescent mononuclear iridium complexes [1]3+-[4]3+ using NEt3-appended C^N chelating benzimidazole (L1-L4) and semi-flexible phenanthroline-pyrazine-based (phpy) ligands exhibiting photocatalytic reduction of 4-nitrophenol (4-NP) in the presence of NEt3 in an aqueous medium. The formation of [1]3+-[4]3+ was confirmed by HRMS, 1H-1H COSY, and 13C and 19F NMR spectroscopy. The complex [4]3+ is water soluble, whereas the others ([1]3+-[3]3+) are partially soluble. The complexes are luminescent in both CH3CN and H2O media. The DFT study reveals that the HOMO of [1]3+ resides on the C^N chelating benzimidazole and iridium center. However, it moves to the pyrazine-pyridine of the phpy unit in the case of [2]3+-[4]3+. The LUMOs are localized on the phenanthroline unit of phpy for all the complexes. This suggests an important role of the fluorine atom on electron density distribution. Spin density analysis demonstrates that the emission bands of the complexes arise from 3MLLCT states. The complex [4]3+ displays promising photocatalytic activity towards 4-NP photoreduction, whereas complexes [1]3+-[3]3+ exhibit lower reactivity. The mechanistic study suggests that the reaction proceeds through an oxidative quenching pathway, where 4-NP is reduced by accepting an electron from excited [Ir(III)] and gets oxidized to Ir(IV), which comes back to its original Ir(III) state by accepting an electron from the sacrificial electron donor NEt3.

Improved transition metal photosensitizers to drive advances in photocatalysis.

To function effectively in a photocatalytic application, a photosensitizer's light absorption, excited-state lifetime, and redox potentials, both in the ground state and excited state, are critically important. The absorption profile is particularly relevant to applications involving solar harvesting, whereas the redox potentials and excited-state lifetimes determine the thermodynamics, kinetics, and quantum yields of photoinduced redox processes. This perspective article focuses on synthetic inorganic and organometallic approaches to optimize these three characteristics of transition-metal based photosensitizers. We include our own work in these areas, which has focused extensively on exceptionally strong cyclometalated iridium photoreductants that enable challenging reductive photoredox transformations on organic substrates, and more recent work which has led to improved solar harvesting in charge-transfer copper(i) chromophores, an emerging class of earth-abundant compounds particularly relevant to solar-energy applications. We also extensively highlight many other complementary strategies for optimizing these parameters and highlight representative examples from the recent literature. It remains a significant challenge to simultaneously optimize all three of these parameters at once, since improvements in one often come at the detriment of the others. These inherent trade-offs and approaches to obviate or circumvent them are discussed throughout.

Cyclometalated Ir(III) theranostic molecular probe enabled mitochondria targeted fluorescence-SERS-guided phototherapy in breast cancer cells

The increased energy demands inherent in cancer cells necessitate a dependence on mitochondrial assistance for their proliferation and metastatic activity. Herein, an innovative photo-medical approach has been attempted, specifically targeting mitochondria, the cellular powerhouses, to attain therapeutic benefit. This strategy facilitates the rapid and precise initiation of apoptosis, the programmed cell death process. In this goal, we have synthesized cyclometalated Iridium (III) molecular probes, denoted as Ir-CN and Ir-H, with a nitrile (CN) and a hydrogen-functionalized bipyridine as ancillary ligands, respectively. Ir-CN has shown superior photosensitizing properties and lower dark cytotoxicity compared to Ir-H in the breast cancer cell line MCF-7, positioning it as the preferred probe for photodynamic therapy (PDT). The synthesized Ir-CN induces alterations in mitochondrial membrane potential, disrupting the respiratory chain function, and generating reactive oxygen species that activate signaling pathways leading to cell death. The CN-conjugated bipyridine ligand in Ir-CN contributes to the intense red fluorescence and the positive charge on the central metal atom facilitates specific mitochondrial colocalization (colocalization coefficient of 0.90). Together with this, the Iridium metal, with strong spin-orbit coupling, efficiently generates singlet oxygen with a quantum yield of 0.79. Consequently, the cytotoxic singlet oxygen produced by Ir-CN upon laser exposure disrupts mitochondrial processes, arresting the electron transport chain and energy production, ultimately leading to programmed cell death. This mitochondrial imbalance and apoptotic induction were dually confirmed through various apoptotic assays including Annexin V staining and by mapping the molecular level changes through surface-enhanced Raman spectroscopy (SERS). Therefore, cyclometalated Ir-CN emerges as a promising molecular probe for cancer theranostics, inducing laser-assisted mitochondrial damage, as tracked through bimodal fluorescence and SERS.

Photoluminescent and electrochemiluminescent detection of homocysteine based on bifunctional cyclometalated iridium(III) complex

A photoluminescent (PL) and electrochemiluminescent (ECL) chemodosimeter for homocysteine (Hcy) determination was developed based on a bifunctional cyclometalated iridium(III) complex (pba)2Ir(dcbpy). (pba)2Ir(dcbpy) was prepared by using 4′-(2-pyridyl)-benzaldehyde (pba) as main ligand and 2,2′-bipyridyl-4,4′-dicarboxylic acid (dcbpy) as ancillary ligand. The existence of aldehyde group on the main ligand and dicarboxylic acid groups on the ancillary ligand endows (pba)2Ir(dcbpy) good water solubility. Importantly, the aldehyde group on the main ligand also furnishes the chemodosimetric active site, which could react with Hcy highly in neutral buffer solution based on a unique cyclization reaction with aminoalkylthiol group to produce a binding adduct, enhancing both PL and ECL signal. The photophysical and ECL properties of (pba)2Ir(dcbpy) in the absence and presence of Hcy were investigated and the response mechanism of the luminescence enhancement was confirmed by mass spectrum. Both PL and ECL measurements exhibited good linear relationships to the Hcy with the detection of limit at micro-molar level. More significantly, (pba)2Ir(dcbpy) possessed a relatively high discriminating ability to differentiate Hcy from structurally related molecule (cysteine) under neutral buffer conditions. The PL and ECL chemodosimeter based on cyclometalated iridium(III) complex with specific active site is universal to the analysis of other targets, thus opening a new avenue for the application of cyclometalated iridium(III) complex in PL and ECL field.

Trifluoromethyl substituted cationic cyclometallated iridium(III) complexes: Photophysical properties and theoretical studies

Three new trifluoromethyl substituted (–CF3) cationic iridium(III) complexes 1–3, with 3,5-dimethyl-1-(3-(trifluoromethyl)phenyl)-1H-pyrazole (DTPP) as the cyclometallated ligand, namely, [Ir(DTPP)2bpy](PF6) (1, bpy = 2, 2′–bipyridine), [Ir(DTPP)2phen](PF6) (2, phen = 1,10-phenanthroline) and [Ir(DTPP)2pphen](PF6) (3, pphen = pyrazino[2,3-f][1,10]phenanthroline) have been rationally designed and synthesized in good yields (60–77%). The photophysical, electrochemical, and electroluminescent properties were fully characterized. Complexes 1–3 show bright blue to yellow emission in the both solution and neat film states with maximum emission wavelength in the range of 484–560 nm. Photoluminescence quantum yields (PLQYs) are very high ranging from 62% to 72% in the solution state with microsecond excited-state lifetimes (0.39–0.77 μs). More detailed photophysical and theortical calculation studies reveal that introduction of –CF3 substituent onto the cyclometallated ligand can induce a blue-shift emission compared with conventional fluorinated phenylpyridine or phenylpyrazole complexes, which can be contributed to the decline in HOMO energy level of complexes. Single-crystal structure analysis of complex 3 shows a distorted octahedral geometry with strong intermolecular π–π stacking (face-to-face) interactions between ancillary ligands in adjacent molecules, which might be responsible for the obviously red-shifted emission compared with complexes 1 and 2 in the aggregated state. In addition, electroluminescent properties of all three new complexes have been studied in the application of light-emitting electrochemical cells (LECs), which show green to yellow electroluminescence (λmax, EL = 516–540 nm).

Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.

Photodynamic therapy (PDT) has emerged as an efficient and noninvasive treatment approach utilizing laser-triggered photosensitizers for combating cancer. Within this rapidly advancing field, iridium-based photosensitizers with their dual functionality as both imaging probes and PDT agents exhibit a potential for precise and targeted therapeutic interventions. However, most reported classes of Ir(III)-based photosensitizers comprise mononuclear iridium(III), with very few examples of dinuclear systems. Exploring the full potential of iridium-based dinuclear systems for PDT applications remains a challenge. Herein, we report a dinuclear Ir(III) complex (IRDI) along with a structurally similar monomer complex (IRMO) having 2-(2,4-difluorophenyl)pyridine and 4'-methyl-2,2'-bipyridine ligands. The comparative investigation of the mononuclear and dinuclear Ir(III) complexes showed similar absorption profiles, but the dinuclear derivative IRDI exhibited a higher photoluminescence quantum yield (Φp) of 0.70 compared to that of IRMO (Φp = 0.47). Further, IRDI showed a higher singlet oxygen generation quantum yield (Φs) of 0.49 compared to IRMO (Φs = 0.28), signifying the enhanced potential of the dinuclear derivative for image-guided photodynamic therapy. In vitro assessments indicate that IRDI shows efficient cellular uptake and significant photocytotoxicity in the triple-negative breast cancer cell line MDA-MB-231. In addition, the presence of a dual positive charge on the dinuclear system facilitates the inherent mitochondria-targeting ability without the need for a specific targeting group. Subcellular singlet oxygen generation by IRDI was confirmed using Si-DMA, and light-activated cellular apoptosis via ROS-mediated PDT was verified through various live-dead assays performed in the presence and absence of the singlet oxygen scavenger NaN3. Further, the mechanism of cell death was elucidated by an annexin V-FITC/PI flow cytometric assay and by investigating the cytochrome c release from mitochondria using Western blot analysis. Thus, the dinuclear complex designed to enhance spin-orbit coupling with minimal excitonic coupling represents a promising strategy for efficient image-guided PDT using iridium complexes.

Cascading Energy Transfer for Highly Efficient Deep-Red OLED Emission with Cyclometalated [3+2+1] Iridium Complexes.

The promising cyclometalated iridium (III) complexes have been proved to possess great potential in vacuum-deposited organic light-emitting diodes (OLEDs) applications for full-color displays and white solid-state lighting sources. Herein, based on the unique bidentate ligand of dibenzo[a,c]phenazine (dbpz) group with strong conjugated effect of aromatic rings for red emission, four novel [3+2+1] coordinated iridium (III) emissive materials have been rationally designed and synthesized. The monodentate ligands of -CN and -OCN have been effectively employed to tune the deep-red emission of 628-675nm with high photoluminescence quantum yields up to 98%. Moreover, all devices displayed deep-red color coordinates ranging from (0.675, 0.325) to (0.716, 0.284), which is close to the standard-red color coordinates of (0.708, 0.292), as recommended by International Telecommunication Union Radiocommunication (ITU-R) BT.2020. The device based on nBuIr(dbpz)CN with an exciplex cohost has exhibited maximum external quantum efficiencies of 20.7% and good stability. With nBuIr(dbpz)CN as an effective sensitizer, the nBuIr(dbpz)OCN based phosphorescent OLED devices have successfully demonstrated cascading energy transfer processes, contributing to pure red emission with maximum luminance as high as 6471cd m-2. Therefore, this work has been successfully demonstrated rational molecular design strategy of [3+2+1] iridium complexes to obtain highly efficient deep-red electrophosphorescent emission.

Recent Advancement in the Synthesis of Ir-Based Complexes.

Cancer is a devastating disease with over 100 types, including lung and breast cancer. Cisplatin and metal-based drugs are limited due to their drug resistance and side effects. Iridium-based compounds have emerged as promising candidates due to their unique chemical properties and resemblance to platinum compounds. The objective of this study is to investigate the synthesis and categorization of iridium complexes, with a particular emphasis on their potential use as anticancer agents. The major focus of this research is to examine the synthesis of these complexes and their relevance to the field of cancer treatment. The negligible side effects and flexibility of cyclometalated iridium(III) complexes have garnered significant interest. Organometallic half-sandwich Ir(III) complexes have notable benefits in cancer research and treatment. The review places significant emphasis on categorizing iridium complexes according to their ligand environment, afterward considering the ligand density and coordination number. This study primarily focuses on several methods for synthesizing cyclometalated and half-sandwich Ir complexes, divided into subgroups based on ligand denticity. The coordination number of iridium complexes determines the number of ligands coordinated to the central iridium atom, which impacts their stability and reactivity. Understanding these complexes is crucial for designing compounds with desired properties and investigating their potential as anticancer agents. Cyclometalated iridium(III) complexes, which contain a meta-cycle with the E-M-C order σ bond, were synthesized in 1999. These complexes have high quantum yields, significant stock shifts, luminescence qualities, cell permeability, and strong photostability. They have been promising in biosensing, bioimaging, and phosphorescence of heavy metal complexes.

Optical modulation of Iridium(III) complexes for enhanced ROS generation: Multi-photon absorption and near-infrared photodynamic therapy insights

In this study, we harness optical modulation techniques to tailor an auxiliary ligand, thereby optimizing the photophysical behavior of cyclometalated iridium (III) complexes, Ir–B and Ir-Q, for enhanced reactive oxygen species (ROS) generation. Intriguingly, the optical properties of Ir-Q's auxiliary ligands instigate a non-radiative intersystem crossover process, yielding a superior singlet oxygen (1O2) quantum efficiency of 0.92. Further, Ir-Q's robust multi-photon absorption spectra, particularly in the Two-photon (750–800 nm) and Three-photon (1350–1600 nm) domains, open avenues for potential applications in two-photon imaging-guided photodynamic therapy targeting deep-seated tumors. This investigation underscores the pivotal role of optical structure modulation in amplifying the therapeutic potential of the iridium(III) complex, particularly in the realm of near-infrared photodynamic therapy.

Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy

In this study, we synthesized 4 cyclometalated iridium complexes using N-(1,10-phenanthrolin-5-yl)picolinamide (PPA) as the main ligand, denoted as [Ir(ppy)2PPA]PF6 (ppy = 2-phenylpyridine, Ir1), [Ir(bzq)2PPA]PF6 (bzq = benzo[h]quinoline, Ir2), [Ir(dfppy)2PPA]PF6 (dfppy = 2-(3,5-difluorophenyl)pyridine, Ir3), and [Ir(thpy)2PPA]PF6 (thpy = 2-(thiophene-2-yl)pyridine, Ir4). Compared to cisplatin and oxaliplatin, all four complexes exhibited significant anti-tumor activity. Among them, Ir2 demonstrated higher cytotoxicity against A549 cells, with an IC50 value of 1.6 ± 0.2 μM. The experimental results indicated that Ir2 primarily localized in the mitochondria, inducing a large amount of reactive oxygen species (ROS) generation, that decreased in mitochondrial membrane potential (MMP), reduced ATP production, and further impaired mitochondrial function, leading to cytochrome c release. Additionally, Ir2 caused cell cycle arrest at the S phase and induced apoptosis through the AKT-mediated signaling pathway. Further investigations revealed that Ir2 could simultaneously induce both apoptosis and autophagy in A549 cells, with the latter acting as a non-protective mechanism that promoted cell death. More importantly, Ir2 exhibited low toxicity to both normal LO2 cells in vitro and zebrafish embryos in vivo. Consequently, these newly developed Ir(III) complexes show great potential in the development of novel and low-toxicity anticancer agents.

Electrochemiluminescence bioassay with anti-fouling ability for determination of matrix metalloproteinase 9 secreted from living cells under external stimulation.

An electrochemiluminescence (ECL) bioassay with high sensitivity and anti-fouling ability was developed for determination of matrix metalloproteinase 9 (MMP-9) secreted from living cells under external stimulation. A peptide with sequence of CLGRMGLPGK and a new cyclometalated iridium(III) complex bearing carboxyl group, (pq)2Ir(dcbpy) (pq = 2-phenylquinoline, dcbpy = 2,2'-bipyridyl-4,4'-dicarboxyli acid, abbreviated as Ir) were employed as molecular recognition substrate and ECL emitter, respectively. The peptide was labelled with the Ir to form Ir-peptide as ECL probe. Ir-peptide was self-assembled onto Nafion and gold nanoparticles (AuNPs) modified glassy carbon electrode (AuNPs/Nafion/GCE) and then both of 6-mercapto-1-hexanol (MCH) and zwitterionic peptide as blocking reagents were co-assembled on Ir-peptide/AuNPs/Nafion/GCE to form an anti-fouling ECL peptide-based biosensor. MMP-9 can be quantified in the range 1.0-50ng·mL-1 with adetection limit of 0.50ng·mL-1 based on the decreased ECL intensity. Relative standard derivation was 2.3% for six fabricated anti-fouling ECL peptide-based biosensors after reaction with 50ng·mL-1 MMP-9. The anti-fouling ECL peptide-based biosensor can be used to monitor MMP-9 secreted from living cells under external stimulation. 96.0%-108.0% of recoveries were obtained in 60-diluted cell culture media. This study demonstrates that the ECL biosensor by the combination of iridium(III) complex-based sensitive ECL method and the anti-fouling interface provides a promising way for the determination of MMP-9 in biological sample, which is viable in clinical diagnosis and point-of-care test of protease.

Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments

Cyclometalated iridium complexes with mitochondrial targeting show great potential as substitutes for platinum-based complexes because of their strong anti-cancer properties. Three novel cyclometalated iridium(III) compounds were synthesized and evaluated in five different cell lines as part of the ongoing systematic investigations of these compounds. The complexes were prepared using 4,7-dichloro-1,10-phenanthroline ligands. The cytotoxicity of complexes Ir1-Ir3 towards HeLa cells was shown to be high, with IC50 values of 0.83±0.06, 4.73±0.11, and 4.95±0.62 μM, respectively. Complex Ir1 could be ingested by HeLa cells in 3 h and has shown high selectivity toward mitochondria. Subsequent investigations demonstrated that Ir1 triggered apoptosis in HeLa cells by augmenting the generation of reactive oxygen species (ROS), reducing the mitochondrial membrane potential, and depleting ATP levels. Furthermore, the movement of cells was significantly suppressed and the progression of the cell cycle was arrested in the G0/G1 phase following the administration of Ir1. The Western blot analysis demonstrated that the induction of apoptosis in HeLa cells by Ir1 involves the activation of the mitochondria-dependent channel and the PI3K/AKT signaling pathway. No significant cytotoxicity was observed in zebrafish embryos at concentrations less than or equal to 16 µM, e.g., survival rate and developmental abnormalities. In vivo, antitumor assay demonstrated that Ir1 suppressed tumor growth in mice. Therefore, our work shows that complex Ir1 could be a promising candidate for developing novel antitumor drugs.

Synthesis, Structure, and Catalytic Activity of Cyclometalated Iridium Complexes with a Bidentate POC Ligand

AbstractSynthesis, characterization and catalytic activity of cyclometalated iridium complexes with a bidentate POC ligand is presented. Metalation of POC‐H (di‐tert‐butyl(phenoxy)phosphane) with [Ir(COD)Cl]2 proceeded rapidly at room temperature and afforded mixture of (POC)(POC‐H)IrHCl (1 a) and (POC)(COD)IrHCl (1 b), from which complexes (POC)(L)IrHCl where L=PPh3 (1 c), bipyridine (1 d) and [2,2′‐bipyridine]‐6,6′‐diol (1 e) were prepared through ligand exchange. The compounds were tested in acceptorless dehydrogenation of 1‐phenylethanol and transfer dehydrogenation of ethanol in a context of comparison with pincer counterparts (POCOP)IrHCl and (PCN)IrHCl. An attempt to prepare a dihydride complex from 1 e led to dimeric complex [(POC)(bipy‐diol−)IrH]2 (3) that could explain the low activity of 1 e. DFT studies provided insight into POC‐H vs POCOP‐H metalation mechanism.

Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis

Immunotherapy has been shown to provide superior antitumor efficacy by activating the innate immune system to recognize, attack and eliminate tumor cells without seriously harming normal cells. Herein, we designed and synthesized three new cyclometalated iridium(III) complexes (Ir1, Ir2, Ir3) then evaluated their antitumor activity. When co-incubated with HepG2 cells, the complex Ir1 localized in the lysosome, where it induced paraptosis and endoplasmic reticulum stress (ER stress). Notably, Ir1 also induced immunogenic cell death (ICD), promoted dendritic cell maturation that enhanced effector T cell chemotaxis to tumor tissues, down-regulated proportions of immunosuppressive regulatory T cells within tumor tissues and triggered activation of antitumor immunity throughout the body. To date, Ir1 is the first reported iridium(III) complex-based paraptosis inducer to successfully induce tumor cell ICD. Furthermore, Ir1 induced ICD of HepG2 cells without affecting cell cycle or reactive oxygen species levels.

Insights into the Luminescence Quantum Yields of Cyclometalated Iridium(III) Complexes: A Density Functional Theory and Machine Learning Approach.

Cyclometalated iridium(III) complexes have been used in various optical materials, including organic light-emitting diodes (OLEDs) and photocatalysts, and a deeper understanding and prediction of their luminescence quantum yields (LQYs) greatly aid in accelerating material design. In this study, we integrated density functional theory (DFT) calculations with machine learning (ML) techniques to extract factors controlling LQY. Although a substantial data set of Ir(III) complexes and their LQYs is indispensable for constructing accurate ML models to predict LQYs, generating this type of data set is challenging due to the complexities associated with ab initio calculations of LQYs. To address this issue, we investigated the nonradiative decay process of nine Ir(III) complexes emitting blue to green, each exhibiting varying experimental LQYs, by using DFT calculations. For all nine complexes, the quenching process was induced by the rotation of the single bond in one of the ligands, which converted the six-coordinate structure to the five-coordinate structure. Since the decay mechanism was common for the nine Ir(III) complexes, parameters correlated with LQYs could be used as objective variables instead of LQYs. Based on this idea, we collected a data set featuring Ir(III) complexes and the energy differences between their six- and five-coordinate triplet structures, which correlated with LQYs. We also constructed ML models using the calculated LQYs as the objective variables with the parameters from the ground-state calculations as explanatory variables. The analyses of the constructed model revealed that the LUMO energy of the ligand made the most significant negative contribution to LQY. This suggests that the potential energy surface of the metal-to-ligand charge transfer (MLCT) excited state, which stabilizes the six-coordinate structure, is reduced by decreasing the energy of the unoccupied orbitals.

Unlocking Efficient High‐Order Multiphoton‐Excited Fluorescence of Metal‐Organic Framework via Octupolar Module In Situ Formation

AbstractEngineering high‐order multiphoton excited fluorescent (H‐MPEF) materials is of significant importance for sensing, 3D optical data storage and bioimaging. However, it remains a challenging endeavor due to a lack of appropriate construction strategies. This study demonstrates that incorporating octupolar modules within metal‐organic framework (MOF) offers new possibilities for the design of highly attractive H‐MPEF materials. Constructed from a typical MOF (UiO(bpdc)), the in situ formation of multibranched octupolar cyclometallated iridium(III) modules via post‐ligand coordination modification endowed the framework with enlarged static hyperpolarizabilities, an extended conjugated system, and enhanced charge transfer, ultimately unlocking its second near‐infrared (NIR‐II, 1000–1700 nm) light activated H‐MPEF performance including three‐ and four‐photon activity. Moreover, these exciting features, combined with subsequent orotic acid‐capping, enabled its application in cancer cell‐specific targeting oncotherapy using tissue‐penetrating NIR‐II light. This finding highlights the vital role of octupoles in H‐MPEF performance and sets a benchmark for unlocking the multiphoton activity of MOFs at the molecular level for deep‐seated tumor fluorescence imaging and therapy.

Optical Resolution of Carboxylic Acid Derivatives of Homoleptic Cyclometalated Iridium(III) Complexes via Diastereomers Formed with Chiral Auxiliaries.

We report on a facile method for the optical resolution of cyclometalated iridium(III) (Ir(III)) complexes via diastereomers formed with chiral auxiliaries. The racemic carboxylic acids of Ir(III) complexes (fac-4 (fac-Ir(ppyCO2H)3 (ppy: 2-phenylpyridine)), fac-6 (fac-Ir(tpyCO2H)3 (tpy: 2-(4'-tolyl)pyridine)), and fac-13 (fac-Ir(mpiqCO2H)3 (mpiq: 1-(4'-methylphenyl)isoquinoline))) were converted into the diastereomers, Δ- and Λ-forms of fac-9 (from fac-6), fac-10 (from fac-4), fac-11 (from fac-6), and fac-14 (from fac-13), respectively, by the condensation with (1R,2R)-1,2-diaminocyclohexane or (1R,2R)-2-aminocyclohexanol. The resulting diastereomers were separated by HPLC (with a nonchiral column) or silica gel column chromatography, and their absolute stereochemistry was determined by X-ray single-crystal structure analysis and CD (circular dichroism) spectra. Spectra of all diastereomers of the Ir(III) complexes are reported. Hydrolysis of the ester moieties of Δ- and Λ-forms of fac-10, fac-11, and fac-14 gave both enantiomers of the corresponding carboxylic acid derivatives in the optically pure forms, Δ-fac and Λ-fac-4, -6, and -13, respectively.